MedPath

Westar

Brand Name: Westar

Generic Name: Trimetazidine Dihydrochloride

Active
Registration Number

DRP-13347

Dosage Form

Modified Release Tablet

Issuance Date

February 1, 2023

Expiry Date

February 1, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength35 mg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Trimetazidine DihydrochlorideActive
Monograph: Trimetazidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform